KAZIA THERAPEUTICS-SPON ADR (KZIA) Stock Price & Overview
NASDAQ:KZIA • US48669G3039
Current stock price
The current stock price of KZIA is 8.99 USD. Today KZIA is up by 1.93%. In the past month the price increased by 20.03%. In the past year, price increased by 172.42%.
KZIA Key Statistics
- Market Cap
- 102.728M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.76
- Dividend Yield
- N/A
KZIA Stock Performance
KZIA Stock Chart
KZIA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to KZIA. When comparing the yearly performance of all stocks, KZIA is one of the better performing stocks in the market, outperforming 95.66% of all stocks.
KZIA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to KZIA. KZIA has a bad profitability rating. Also its financial health evaluation is rather negative.
KZIA Earnings
On March 19, 2026 KZIA reported an EPS of -0.8 and a revenue of 253.00K. The company missed EPS expectations (-142.84% surprise) and beat revenue expectations (396.08% surprise).
KZIA Forecast & Estimates
8 analysts have analysed KZIA and the average price target is 19.38 USD. This implies a price increase of 115.57% is expected in the next year compared to the current price of 8.99.
For the next year, analysts expect an EPS growth of 79.58% and a revenue growth -25.37% for KZIA
KZIA Groups
Sector & Classification
KZIA Financial Highlights
Over the last trailing twelve months KZIA reported a non-GAAP Earnings per Share(EPS) of -1.76. The EPS increased by 94.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -32.06% | ||
| ROE | -49.07% | ||
| Debt/Equity | 0 |
KZIA Ownership
KZIA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.92 | 367.796B | ||
| AMGN | AMGEN INC | 15.32 | 189.224B | ||
| GILD | GILEAD SCIENCES INC | 15.73 | 172.517B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.59 | 110.97B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.92 | 79.171B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 48.79 | 42.718B | ||
| INSM | INSMED INC | N/A | 33.416B | ||
| NTRA | NATERA INC | N/A | 27.358B | ||
| BIIB | BIOGEN INC | 10.94 | 25.385B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.76 | 25.059B | ||
| MRNA | MODERNA INC | N/A | 20.21B | ||
| INCY | INCYTE CORP | 12.34 | 19.119B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.11B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About KZIA
Company Profile
The company is headquartered in Sydney, New South Wales.
Company Info
IPO: 1994-09-01
KAZIA THERAPEUTICS-SPON ADR
Three International Towers Level 24,, 300 Barangaroo Avenue
Sydney NEW SOUTH WALES 2000 AU
CEO: James Garner
Employees: 6
Phone: 61294724100
KAZIA THERAPEUTICS-SPON ADR / KZIA FAQ
What does KZIA do?
The company is headquartered in Sydney, New South Wales.
Can you provide the latest stock price for KAZIA THERAPEUTICS-SPON ADR?
The current stock price of KZIA is 8.99 USD. The price increased by 1.93% in the last trading session.
Does KZIA stock pay dividends?
KZIA does not pay a dividend.
What is the ChartMill rating of KAZIA THERAPEUTICS-SPON ADR stock?
KZIA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is KAZIA THERAPEUTICS-SPON ADR (KZIA) stock traded?
KZIA stock is listed on the Nasdaq exchange.
Can you provide the PE ratio for KZIA stock?
KAZIA THERAPEUTICS-SPON ADR (KZIA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.76).
What is the Short Interest ratio of KAZIA THERAPEUTICS-SPON ADR (KZIA) stock?
The outstanding short interest for KAZIA THERAPEUTICS-SPON ADR (KZIA) is 2.29% of its float.